Figures for Interest Grows in Treatment of Mood Disorders by Classic Psychedelics

Article

This is the extra table for "Interest Grows in Treatment of Mood Disorders by Classic Psychedelics."

Table. Registered Clinical Trials on ClinicalTrials.gov

Table. Registered Clinical Trials on ClinicalTrials.gov

Related Videos
Related Content
Here are highlights from the week in Psychiatric Times.

The Week in Review: April 15-19

April 20th 2024
Article
Here's to a Psychedelic Revolution

Here's to a Psychedelic Revolution

April 9th 2022
Podcast
Study results suggest the potential for a scalable, single-dose treatment approach.

Publication of Phase 1 Results Announced for BPL-003

April 17th 2024
Article
Blue Light, Depression, and Bipolar Disorder

Blue Light, Depression, and Bipolar Disorder

August 4th 2021
Podcast
“The selectivity of NBI-1070770 for the NMDA NR2B receptor may benefit patients with moderate to severe depression.”

First Patient Dosed in Phase 2 Clinical Trial of NBI-1070770 for MDD

April 3rd 2024
Article
The experts weighed in on a wide variety of psychiatric issues for the March 2024 issue of Psychiatric Times.

From the Pages of Psychiatric Times: March 2024

March 30th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.